Preliminary phase II data with COVID-19 vaccine candidate GRAd-COV2 support progression July 12, 2021
Ampligen to be studied in phase IIa human challenge trial as intranasal antiviral therapy July 12, 2021
Safety monitoring committee recommends continuation of phase IIb study of RV-001 in prostate cancer July 12, 2021
ViiV initiates phase II study of GSK-3810109A in antiretroviral-naive HIV-1-infected adults July 12, 2021
RSS